How the FDA is using real-world evidence in safety and approval decisions
Regulatory decision-making depends on evidence that reflects how medical products perform in...
Regulatory decision-making depends on evidence that reflects how medical products perform in...
Our team had a great time at HCIC connecting with healthcare marketers, digital teams and consumer...
Identifying the gaps in today’s real-world data The 2025 IMPACCT Real-World Evidence Summit brought...
Thank you for visiting HealthVerity at Fierce 2025 HealthVerity had a fantastic week at Fierce...
At HealthVerity, community is at the heart of who we are. Each year, our team members come together...
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
With the start of 2024, we are moving toward a world without third-party cookies to track consumer...
With recent disruptions in the availability of real-world data (RWD) for clinical research,...
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world evidence...